{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:16:17Z","timestamp":1770506177315,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jconrel.2004.11.001","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T12:42:09Z","timestamp":1102077729000},"page":"669-677","source":"Crossref","is-referenced-by-count":31,"title":["Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon"],"prefix":"10.1016","volume":"102","author":[{"given":"Y.","family":"Zambito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Baggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Colo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2004.11.001_bib1","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"1225","article-title":"Chemotherapy of neoplastic diseases","author":"Calabresi","year":"1996"},{"key":"10.1016\/j.jconrel.2004.11.001_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/1097-0142(197504)35:4<1031::AID-CNCR2820350403>3.0.CO;2-N","article-title":"A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma","volume":"35","author":"Hahn","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2004.11.001_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2004.11.001_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2003.10.017","article-title":"Drug targeting to the colon with lectins and neoglycoconjugates","volume":"56","author":"Minko","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2004.11.001_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10717540490280778","article-title":"Polysaccharides for colon targeted drug delivery","volume":"11","author":"Chourasia","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2004.11.001_bib6","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/S0142-9612(03)00213-8","article-title":"Pectin-based systems for colon-specific drug delivery via oral route","volume":"24","author":"Liu","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2004.11.001_bib7","first-page":"33","article-title":"Pharmaceutical approaches to colon targeted drug delivery systems","volume":"6","author":"Chourasia","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.11.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00004-2","article-title":"Colon-specific drug delivery: new approaches and in vitro\/in vivo evaluation","volume":"235","author":"Yang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0928-0987(02)00081-7","article-title":"In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil","volume":"16","author":"Krishnaiah","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.11.001_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-3659(03)00195-0","article-title":"Microsphere design for the colonic delivery of 5-fluorouracil","volume":"90","author":"Lamprecht","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2004.11.001_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2003.09.036","article-title":"Colonic drug delivery of 5-fluorouracil: an in vitro evaluation","volume":"269","author":"Sinha","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(01)00871-7","article-title":"Enteric coated HPMC capsules designed to achieve intestinal targeting","volume":"231","author":"Cole","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/js970018g","article-title":"Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon","volume":"86","author":"Tozaki","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.11.001_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(03)00229-1","article-title":"Physical and thermal characterisation of Precirol\u00ae and Compritol\u00ae as lipophilic glycerides used for the preparation of controlled-release matrix pellets","volume":"260","author":"Hamdani","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(02)00421-0","article-title":"Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide)","volume":"248","author":"Di Colo","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib16","volume":"vol. XXII","author":"Gennaro","year":"1990"},{"key":"10.1016\/j.jconrel.2004.11.001_bib17","first-page":"274","article-title":"Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery","volume":"6","author":"Zambito","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.11.001_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-5173(99)00196-9","article-title":"Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets","volume":"187","author":"Macleod","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2003.11.009","article-title":"Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release","volume":"270","author":"Ofori-Kwakye","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.11.001_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2004.02.023","article-title":"Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans","volume":"97","author":"Goto","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2004.11.001_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2004.11.001_bib22","series-title":"Oral Colon-Specific Drug Delivery","first-page":"1","article-title":"Anatomy and physiology of the gastrointestinal tract: implication for colonic drug delivery","author":"Haberlin","year":"1992"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365904005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365904005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T09:54:19Z","timestamp":1549014859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365904005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0168365904005322"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2004.11.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}